Élisabeth Carola

OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study

Christophe Tournigand, Andrés Cervantes, Arié Figer et al. · Journal of Clinical Oncology · 2006 · 799 citations

Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study

Benoist Chibaudel, Frédérique Maindrault‐Gœbel, Gérard Lledo et al. · Journal of Clinical Oncology · 2009 · 394 citations

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

F. Maindrault-Gœbel, Christophe Louvet, Thierry André et al. · European Journal of Cancer · 1999 · 287 citations

Oncology, 5-Fluorouracil Regimen, Medicine +6

Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and Fluorouracil Regimen

Thierry André, M.A. Bensmaïne, Christophe Louvet et al. · Journal of Clinical Oncology · 1999 · 280 citations

CPT-11 (Irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer

Thierry André, Christophe Louvet, F. Maindrault-Gœbel et al. · European Journal of Cancer · 1999 · 268 citations

Oncology, Gastrointestinal Oncology, Medicine +8